ALPHARMA INC (ALO) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 375 transactions totaling $18.7M, demonstrating a bearish sentiment with -$16.7M in net insider flow. The most recent transaction on Dec 29, 2008 involved a transaction of 1,500 shares valued at $0.
No significant insider buying has been recorded for ALO in the recent period.
No significant insider selling has been recorded for ALO in the recent period.
Based on recent SEC filings, insider sentiment for ALO is bearish with an Insider Alignment Score of 5/100 and a net flow of -$16.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ALPHARMA INC (ALO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading ALO stock, having executed 375 transactions in the past 90 days. The most active insider is Matthew Farrell (Executive), who has made 8 transactions totaling $6.7M.
Get notified when executives and directors at ALO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 29, 2008 | C. Uprichard David | Executive | Disposition | 1,500 | $N/A | $0 | |
| Dec 29, 2008 | Wrenn Carol | Executive | Disposition | 4,356 | $N/A | $0 | |
| Dec 29, 2008 | Wrenn Carol | Executive | Disposition | 4,615.2 | $N/A | $0 | |
| Dec 29, 2008 | Joseph Del Buono | Executive | Disposition | 838 | $N/A | $0 | |
| Dec 29, 2008 | Joseph Del Buono | Executive | Disposition | 98.67 | $N/A | $0 | |
| Dec 29, 2008 | Tombros Peter | Executive | Disposition | 4,818 | $N/A | $0 | |
| Dec 29, 2008 | Campbell Jeffrey | Executive | Disposition | 7,773 | $N/A | $0 | |
| Dec 29, 2008 | Campbell Jeffrey | Executive | Disposition | 170.2 | $N/A | $0 | |
| Dec 29, 2008 | J. Mitchell Dean | Executive | Disposition | 12,931 | $N/A | $0 | |
| Dec 29, 2008 | J. Mitchell Dean | Executive | Disposition | 309.68 | $N/A | $0 | |
| Dec 29, 2008 | Buzinkai Donald | Executive | Disposition | 92.52 | $N/A | $0 | |
| Dec 29, 2008 | Buzinkai Donald | Executive | Disposition | 401 | $N/A | $0 | |
| Dec 29, 2008 | J. Spellman Thomas III | Executive | Disposition | 159.57 | $N/A | $0 | |
| Dec 29, 2008 | J. Spellman Thomas III | Executive | Disposition | 942 | $N/A | $0 | |
| Dec 29, 2008 | W. Peter Ladell | Executive | Disposition | 3,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 126 | $17.7M | 62.7% |
Exercise(M) | 64 | $8.0M | 28.3% |
Payment(F) | 31 | $1.2M | 4.4% |
Purchase(P) | 61 | $975.5K | 3.5% |
Disposition(D) | 22 | $307.8K | 1.1% |
Award(A) | 45 | $0 | 0.0% |
Other(J) | 26 | $0 | 0.0% |
Insider selling pressure at ALPHARMA INC has increased, with 24 insiders executing 375 transactions across all time. Total sales of $17.7M significantly outpace purchases of $975.5K, resulting in a net outflow of $16.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.